Last reviewed · How we verify
NCT02506712: SmartDrive
Evaluation of Physiological and Biomechanical Efficiency of the PAPAW
NA trial testing SmartDrive assisting device in Spinal Cord Injuries in 44 participants. Completed in 1 October 2017.
1 October 2015
Quick facts
| Lead sponsor | Centre d'Investigation Clinique et Technologique 805 |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 44 |
| Start date | 15 July 2015 |
| Primary completion | 1 October 2015 |
| Estimated completion | 1 October 2017 |
| Sites | 1 location across France |
Drugs / interventions tested
- SmartDrive assisting device
- Standard manuel wheelchair
Conditions studied
- Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
Sponsor
Centre d'Investigation Clinique et Technologique 805 — full company profile →
Who can join
Adults 18 to 70, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to quantify energy expenditure when using the SmartDrive system during manual wheelchair propulsion in external conditions (slope, straight line). For this two comparisons are performed: Comparison of energy expenditure with and without the use of a system SmartDrive 6 minute propulsion test. Comparison the risk of musculoskeletal disorders of the wrist during a 6 minute propulsion test.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02506712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spinal Cord Injuries
Currently open trials in the same condition.
- NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
- NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
- NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
- NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
- NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting
Other Centre d'Investigation Clinique et Technologique 805 trials
Trials by the same sponsor.
- NCT06029192 — Diastolic Function in Myotonic Dystrophy Type 1 · unknown
- NCT05648292 — The Relationships Between Personal Identity, Autobiographical Memory and Future Thinking in People With Multiple Scleros · unknown
- NCT04668430 — Evaluation of Personalized Biomechanical Models of the Musculoskeletal System Before and After Orthopedic Surgeries · NA · unknown
- NCT04652401 — Quality of Life in Ventilator-dependant Neuromuscular Patients · completed
- NCT04562844 — Assessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02506712 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre d'Investigation Clinique et Technologique 805
- Last refreshed: 4 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02506712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing